{"transactions":[{"id":1122734,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T20:46:12.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":8789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":61528,"derivative":{"underlying":"Common Stock","underlying_shares":8789},"source":{"system":"sec-edgar","filing":"0001104659-25-056432","document":"tm2517077-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925056432/tm2517077-1_4seq1.xml","form_type":"4"}},{"id":1122733,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T20:46:12.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4464,"price":1.76,"value":7856.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":60529,"source":{"system":"sec-edgar","filing":"0001104659-25-056432","document":"tm2517077-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925056432/tm2517077-1_4seq1.xml","form_type":"4"}},{"id":1122732,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T20:46:12.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":true,"shares":8789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":64993,"source":{"system":"sec-edgar","filing":"0001104659-25-056432","document":"tm2517077-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925056432/tm2517077-1_4seq1.xml","form_type":"4"}},{"id":1217248,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-08T01:05:11.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":93750,"derivative":{"underlying":"Common stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001104659-25-021866","document":"tm258333-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925021866/tm258333-6_4seq1.xml","form_type":"4"}},{"id":1222195,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T01:33:41.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":58590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The remaining RSUs will vest in equal quarterly installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":70317,"derivative":{"underlying":"Common Stock","underlying_shares":58590},"source":{"system":"sec-edgar","filing":"0001104659-25-021062","document":"tm258333-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925021062/tm258333-5_4seq1.xml","form_type":"4"}},{"id":1222194,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-06T01:33:41.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":31734,"price":4.04,"value":128205.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":56204,"source":{"system":"sec-edgar","filing":"0001104659-25-021062","document":"tm258333-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925021062/tm258333-5_4seq1.xml","form_type":"4"}},{"id":1222193,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-06T01:33:41.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":58590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":87938,"source":{"system":"sec-edgar","filing":"0001104659-25-021062","document":"tm258333-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925021062/tm258333-5_4seq1.xml","form_type":"4"}},{"id":1413733,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T23:52:10.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":false,"shares":23438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The remaining RSUs will vest on the one-year anniversary of the initial grant date, as provided in footnote 7."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The remaining RSUs will vest on the one-year anniversary of the initial grant date, as provided in footnote 7."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person."}],"balance_after":23437,"derivative":{"underlying":"Common Stock","underlying_shares":23438},"source":{"system":"sec-edgar","filing":"0001104659-24-097487","document":"tm2423453-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924097487/tm2423453-1_4seq1.xml","form_type":"4"}},{"id":1413732,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T23:52:10.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11891,"price":10.85,"value":129017.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":29348,"source":{"system":"sec-edgar","filing":"0001104659-24-097487","document":"tm2423453-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924097487/tm2423453-1_4seq1.xml","form_type":"4"}},{"id":1413731,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T23:52:10.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":true,"shares":23438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents such shares underlying the restricted stock units (\"RSUs\") which vested on the transaction date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":41239,"source":{"system":"sec-edgar","filing":"0001104659-24-097487","document":"tm2423453-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924097487/tm2423453-1_4seq1.xml","form_type":"4"}},{"id":1595394,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T22:51:35.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant."}],"balance_after":46875,"derivative":{"underlying":"Common stock","underlying_shares":46875},"source":{"system":"sec-edgar","filing":"0001104659-24-031106","document":"tm248017-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924031106/tm248017-2_4seq1.xml","form_type":"4"}},{"id":1595393,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T22:51:35.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":105470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":105470,"derivative":{"underlying":"Common stock","underlying_shares":105470},"source":{"system":"sec-edgar","filing":"0001104659-24-031106","document":"tm248017-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924031106/tm248017-2_4seq1.xml","form_type":"4"}},{"id":1968837,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T22:24:03.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":168750,"derivative":{"exercise_price":7.12,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001104659-23-029093","document":"tm238642-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465923029093/tm238642-1_4seq1.xml","form_type":"4"}},{"id":2062397,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-06T01:45:10.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":18850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":18850},"source":{"system":"sec-edgar","filing":"0001104659-23-001600","document":"tm232380d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465923001600/tm232380d1_4seq1.xml","form_type":"4"}},{"id":2062396,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-06T01:45:10.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":10553,"price":6.11,"value":64478.83,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":17801,"source":{"system":"sec-edgar","filing":"0001104659-23-001600","document":"tm232380d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465923001600/tm232380d1_4seq1.xml","form_type":"4"}},{"id":2062395,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-06T01:45:10.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":18850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This is the second and final vesting of the restricted stock units (\"RSUs\") issued on June 14, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":28354,"source":{"system":"sec-edgar","filing":"0001104659-23-001600","document":"tm232380d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465923001600/tm232380d1_4seq1.xml","form_type":"4"}},{"id":2229860,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-16T21:03:58.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":18850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents restricted stock units remaining after deducting the vested shares of common stock and common stock withheld for taxes as set forth in Table I above."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date."}],"balance_after":18850,"derivative":{"underlying":"Common stock","underlying_shares":18850},"source":{"system":"sec-edgar","filing":"0001104659-22-071965","document":"tm2218629-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922071965/tm2218629-2_4seq1.xml","form_type":"4"}},{"id":2229859,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-16T21:03:58.000Z","date":"2022-06-14","kind":"tax_withholding","acquired":false,"shares":9346,"price":7.73,"value":72244.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents common stock remaining after deducting the common stock withheld for taxes."}],"balance_after":9504,"source":{"system":"sec-edgar","filing":"0001104659-22-071965","document":"tm2218629-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922071965/tm2218629-2_4seq1.xml","form_type":"4"}},{"id":2229858,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-16T21:03:58.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":18850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This is the first vesting of the restricted stock units issued on June 14, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":18850,"source":{"system":"sec-edgar","filing":"0001104659-22-071965","document":"tm2218629-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922071965/tm2218629-2_4seq1.xml","form_type":"4"}},{"id":2432113,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-20T01:31:04.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":135000,"derivative":{"exercise_price":15.49,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-22-005596","document":"tm223806-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922005596/tm223806-1_4seq1.xml","form_type":"4"}},{"id":2666090,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-16T21:07:26.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units vest as follows: (i) one-half of such shares shall vest and be settled on the one-year anniversary of the date of grant; and (ii) the remaining shares shall vest and be settled on December 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units vest as follows: (i) one-half of such shares shall vest and be settled on the one-year anniversary of the date of grant; and (ii) the remaining shares shall vest and be settled on December 31, 2022."}],"balance_after":37700,"derivative":{"underlying":"Common stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001104659-21-082070","document":"tm2119923-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465921082070/tm2119923-4_4seq1.xml","form_type":"4"}},{"id":2939909,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-17T11:07:59.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":50.26,"expiration_date":"2030-12-14","underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-20-136547","document":"tm2038660d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920136547/tm2038660d2_4.xml","form_type":"4"}},{"id":3243082,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-27T17:26:02.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2020."}],"balance_after":110000,"derivative":{"exercise_price":8.91,"exercise_date":"2020-04-01","expiration_date":"2030-02-24","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001567619-20-005027","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656634/000156761920005027/doc1.xml","form_type":"4"}},{"id":3594718,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":78887,"kind":"person","name":"Bellemin Jean-Marc","position":1,"cik":"0001754253","reported_name":"Bellemin Jean-Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-14T19:11:14.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2019."}],"balance_after":66000,"derivative":{"exercise_price":12.02,"exercise_date":"2019-04-01","expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001567619-19-006915","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656634/000156761919006915/doc1.xml","form_type":"4"}}]}